Literature DB >> 31073724

Down syndrome and infertility: what support should we provide?

Estelle Parizot1,2, Rodolphe Dard1,3, Nathalie Janel2, François Vialard4,5.   

Abstract

Down syndrome (DS) is the most common genetic disease at birth; on average, it affects 1 in 700 newborns. The syndrome features cognitive impairment, susceptibility to certain diseases, and (in some cases) congenital malformations. Improvements in medical care for people with DS have led to an increase in life expectancy. Furthermore, the systematic provision of specific support during childhood improves cognitive function and autonomy in adulthood. Consequently, patients and their families are now seeking the same rights as healthy people. Access to procreation is an emerging debate. The presumption of infertility in DS is based on a few old studies. Down syndrome appears to cause spermatogenesis defects in men and premature menopause in women. When assisted reproductive technology makes it possible to solve these problems, the question of fertility in DS must be addressed. Without entering into highly controversial ethical considerations related to parenthood for people with DS, we reviewed the literature on fertility in DS and tried to specify the associated genetic risk.

Entities:  

Keywords:  Down syndrome; Genetic risk; Infertility; Premature ovarian failure

Mesh:

Year:  2019        PMID: 31073724      PMCID: PMC6603116          DOI: 10.1007/s10815-019-01457-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  6 in total

1.  Efficacy of Letrozole Combined with Urinary Gonadotropin for Ovulation Induction in Endocrine Abnormal Infertility Patients: A Retrospective Single-Center, Case-Control Study.

Authors:  Hao Peng; Ben Yuan; Junbiao Mao; Junling Wang; Shuhong Luo
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

Review 2.  Epidemiology of Male Hypogonadism.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.748

Review 3.  Pharmacological Approaches to the Treatment of Dementia in Down Syndrome: A Systematic Review of Randomized Clinical Studies.

Authors:  Laura Cavalcanti de Oliveira; Daniele de Paula Faria
Journal:  Molecules       Date:  2022-05-19       Impact factor: 4.927

4.  The Second Case of Non-Mosaic Trisomy of Chromosome 26 with Homologous Fusion 26q;26q in the Horse.

Authors:  Sharmila Ghosh; Josefina Kjöllerström; Laurie Metcalfe; Stephen Reed; Rytis Juras; Terje Raudsepp
Journal:  Animals (Basel)       Date:  2022-03-22       Impact factor: 2.752

5.  Why Is Health Care for Children with Down Syndrome So Crucial from the First Days of Life? A Retrospective Cohort Study Emphasized Transient Abnormal Myelopoiesis (TAM) Syndrome at Three Centers.

Authors:  Gabriela Telman; Patrycja Sosnowska-Sienkiewicz; Ewa Strauss; Jan Mazela; Przemysław Mańkowski; Danuta Januszkiewicz-Lewandowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-08       Impact factor: 4.614

6.  Genetic Susceptibility to Periodontal Disease in Down Syndrome: A Case-Control Study.

Authors:  María Fernández; Alicia de Coo; Inés Quintela; Eliane García; Márcio Diniz-Freitas; Jacobo Limeres; Pedro Diz; Juan Blanco; Ángel Carracedo; Raquel Cruz
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.